Hilleman MR - Search Results

1

Live attenuated mumps virus vaccine. 1. Vaccine development.

Buynak EB, Hilleman MR. Buynak EB, et al. Among authors: hilleman mr. Proc Soc Exp Biol Med. 1966 Dec;123(3):768-75. doi: 10.3181/00379727-123-31599. Proc Soc Exp Biol Med. 1966. PMID: 4163620 Clinical Trial. No abstract available.

2

Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines.

Weibel RE, Buynak EB, McLean AA, Hilleman MR. Weibel RE, et al. Among authors: hilleman mr. Proc Soc Exp Biol Med. 1979 Nov;162(2):328-32. doi: 10.3181/00379727-162-40675. Proc Soc Exp Biol Med. 1979. PMID: 515009 No abstract available.

3

Development and chimpanzee testing of a vaccine against human hepatitis B.

Buynak EB, Roehm RR, Tytell AA, Bertland AU 2nd, Lampson GP, Hilleman MR. Buynak EB, et al. Among authors: hilleman mr. Proc Soc Exp Biol Med. 1976 Apr;151(4):694-700. doi: 10.3181/00379727-151-39288. Proc Soc Exp Biol Med. 1976. PMID: 817293

4

Live, attenuated mumps-virus vaccine.

Hilleman MR, Buynak EB, Weibel RE, Stokes J Jr. Hilleman MR, et al. N Engl J Med. 1968 Feb 1;278(5):227-32. doi: 10.1056/NEJM196802012780501. N Engl J Med. 1968. PMID: 4169706 No abstract available.

5

Live, attenuated rubella-virus vaccine.

Hilleman MR, Buynak EB, Weibel RE, Stokes J Jr. Hilleman MR, et al. N Engl J Med. 1968 Aug 8;279(6):300-3. doi: 10.1056/NEJM196808082790607. N Engl J Med. 1968. PMID: 4969117 Review. No abstract available.

6

Live, attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation.

Hilleman MR, Weibel RE, Buynak EB, Stokes J Jr, Whitman JE Jr. Hilleman MR, et al. N Engl J Med. 1967 Feb 2;276(5):252-8. doi: 10.1056/NEJM196702022760502. N Engl J Med. 1967. PMID: 6016061 Clinical Trial. No abstract available.

7

Comparison of neutralization and hemagglutination-inhibition techniques for measuring mumps antibody.

Buynak EB, Whitman JE Jr, Roehm RR, Morton DH, Lampson GP, Hilleman MR. Buynak EB, et al. Among authors: hilleman mr. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1068-71. doi: 10.3181/00379727-125-32278. Proc Soc Exp Biol Med. 1967. PMID: 6042404 No abstract available.

8

Clinical and laboratory studies of KMcC strain live attenuated varicella virus.

Neff BJ, Weibel RE, Villarejos VM, Buynak EB, McLean AA, Morton DH, Wolanski BS, Hilleman MR. Neff BJ, et al. Among authors: hilleman mr. Proc Soc Exp Biol Med. 1981 Mar;166(3):339-47. doi: 10.3181/00379727-166-41071. Proc Soc Exp Biol Med. 1981. PMID: 6259644 Clinical Trial. No abstract available.

9

Clinical and laboratory studies of live attenuated RA 27/3 and HPV 77-DE rubella virus vaccines.

Weibel RE, Villarejos VM, Klein EB, Buynak EB, McLean AA, Hilleman MR. Weibel RE, et al. Among authors: hilleman mr. Proc Soc Exp Biol Med. 1980 Oct;165(1):44-9. doi: 10.3181/00379727-165-40931. Proc Soc Exp Biol Med. 1980. PMID: 6999498 Clinical Trial. No abstract available.

10

Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines.

Weibel RE, Buynak EB, McLean AA, Roehm RR, Hilleman MR. Weibel RE, et al. Among authors: hilleman mr. Proc Soc Exp Biol Med. 1980 Nov;165(2):260-3. doi: 10.3181/00379727-165-40967. Proc Soc Exp Biol Med. 1980. PMID: 7443713 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters